FDA Inspection 1151274 — BECRO Ltd
The FDA completed an inspection of BECRO Ltd on September 10, 2021 in Larissa. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 10, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Larissa (Greece)
Additional Details
Clinical BA/BE